Results
1 -
9 of
9Phase II trial of Cystemustine, a new nitrosourea, as second-line treatment of malignant gliomas, Cancer Treatment An Update Pharmacokinetics of Two New 2-Chloroethylnitrosoureas in Cancer Patients Submitted to Phase II Clinical Trials, Drug Investigation Cystemustine in recurrent high grade glioma, Journal of Neuro-Oncology Phase II Trial of Cystemustine, a New Nitrosourea, as Treatment of High-grade Brain Tumors in Adults, Journal of Neuro-Oncology Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives, BMC Cancer Cancers respond to cystemustine, Inpharma Weekly Cystemustine shows potential in disseminated malignant melanoma, Inpharma Weekly